Protein S-nitrosylation modulates important cellular processes, including neurotransmission, vasodilation, proliferation, and apoptosis in various cell types. We have previously reported that protein disulfide isomerase (PDI) is S-nitrosylated in brains of patients with sporadic neurodegenerative diseases. This modification inhibits PDI enzymatic activity and consequently leads to the accumulation of unfolded/misfolded proteins in the endoplasmic reticulum (ER) lumen. Here, we describe S-nitrosylation of additional ER pathways that affect the unfolded protein response (UPR) in cell-based models of Parkinson's disease (PD). We demonstrate that nitric oxide (NO) can S-nitrosylate the ER stress sensors IRE1α and PERK. While S-nitrosylation of IRE1α inhibited its ribonuclease activity, S-nitrosylation of PERK activated its kinase activity and downstream phosphorylation/inactivation or eIF2α. Site-directed mutagenesis of IRE1α(Cys931) prevented Snitrosylation and inhibition of its ribonuclease activity, indicating that Cys931 is the predominant site of S-nitrosylation. Importantly, cells overexpressing mutant IRE1α(C931S) were resistant to NOinduced damage. Our findings show that nitrosative stress leads to dysfunctional ER stress signaling, thus contributing to neuronal cell death.
The UPR is a stress response that prevents accumulation of unfolded proteins in the ER lumen. Unfolded proteins in the ER are detected by transmembrane ER stress sensors 11, 12 . The three major ER stress-sensing proteins are PKR-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1), and activating transcription factor 6 (ATF6) [13] [14] [15] . These sensors transmit signals from the ER to the cytoplasm or nucleus, and activate the following three pathways: (i) suppression of protein translation to halt the production of more unfolded proteins, (ii) induction of genes encoding ER molecular chaperones to facilitate protein folding, and (iii) activation of ER-associated degradation (ERAD) to decrease the accumulation of unfolded proteins in the ER 16 . NO regulates numerous cell responses associated with proliferation, neurotransmission, synaptic plasticity, or cytotoxicity, in part via protein S-nitrosylation. This redox-mediated chemical modification occurs via oxidative reaction between NO and cysteine (Cys) thiol (or more properly thiolate anion) in the presence of an electron acceptor; alternatively, the reaction can proceed via transnitrosylation from one S-nitrosothiol to another [17] [18] [19] . We previously demonstrated that PDI is a target of NO under neurodegenerative conditions. S-Nitrosylation of PDI (forming SNO-PDI) inhibits its enzymatic activity and induces ER stress 20 . Additionally, we found that NO suppresses expression of mRNAs encoding ER stress markers. Therefore, we postulated that unidentified SNO-proteins might be involved in the UPR. In the present study, we discovered that a number of ER stress-sensing proteins are S-nitrosylated, suggesting a novel regulatory mechanism for UPR activation.
Results
NO regulates the IRE1α pathway during the UPR. We examined mRNA expression of specific ER stress markers in response to NO. Exposure to S-nitrosoglutathione (GSNO), a physiological NO donor, elevated the mRNA expression level of genes encoding BiP, CHOP, and EDEM1, but not HRD1 (Fig. 1a) . Because HRD1 mRNA expression is known to be dependent on XBP1, it is possible that NO regulates this branch of the UPR via IRE1α 21 . To determine if NO modulates the UPR in this manner, we transfected SH-SY5Y neural cells with a vector expressing the fusion gene XBP1-luciferase (Luc) in order to monitor IRE1α activity 22 . Cells transfected with the XBP1-Luc expression vector showed detectable luminescence when treated with thapsigargin (Fig. 1b) . However, exposure to high concentrations of NO did not significantly affect XBP1-Luc reporter activity, consistent with the notion that the IRE1α -XBP1 branch was regulated by NO. In addition, NO did not induce cytosolic splicing of XBP1 mRNA (Fig. 1c) . Next, we asked if NO impaired oligomerization or kinase activity of IRE1α . Empirically, we observed that exposure to NO did not attenuate oligomerization or phosphorylation of IRE1α (Fig. 1d,e) .
Neurotoxin 1-methyl-4-phenylpyridinium (MPP
+ ) and ER stress attenuate the IRE1α pathway in an NO synthase (NOS)-dependent manner. MPP + , which is known to cause a parkinsonian phenotype in rodents, non-human primates and humans, induces NO production and neuronal cell death, at least in part via ER stress 23 . Therefore, we tested whether MPP + affected UPR signaling. We found that MPP + induced mRNA expression of BiP and CHOP in a concentration-dependent manner; however, neither splicing of XBP1 mRNA nor phosphorylation of IRE1α was detected under these conditions (Fig. 2a,b) . To determine whether attenuation of XBP1 mRNA splicing was mediated by NO, we treated SH-SY5Y cells with the NOS inhibitor 7-nitroindazole (7-NI), and found that splicing was significantly ameliorated (Fig. 2c,d ). To further test the effects of ER stress and NO on IRE1α -XBP1 signaling, we induced ER stress with thapsigargin in the presence and absence of exogenous NO. Although thapsigargin clearly stimulated XBP1 mRNA splicing, pre-incubation with NO completely abrogated this response (Fig. 3a,b) . These findings are consistent with the notion that the ribonuclease activity of IRE1α is regulated by redox state, specifically via reaction with NO.
S-Nitrosylation of IRE1α at Cys931 attenuates its ribonuclease activity. Next, we determined if NO could S-nitrosylate the UPR components IRE1α , PERK, or ATF6. By biotin-switch assay, we found that NO mediated S-nitrosylation of IRE1α (to form SNO-IRE1) and PERK (forming SNO-PERK), but not ATF6 (Fig. 4a) . Therefore, we hypothesized that NO may modulate IRE1α endoribonuclease activity by S-nitrosylating the enzyme. Along these lines, two cysteine residues, at positions 931 and 951, are known to reside in the kinase-extension nuclease (KEN) domain of IRE1α 24, 25 . To determine if these residues were the target site(s) of S-nitrosylation, we substituted each cysteine for serine and assessed SNO-IRE1α formation by performing biotin-switch assays. After 24 h, the cells were exposed to S-nitrosocysteine (SNOC) or control conditions and were monitored for SNO-IRE1α formation. We found that the IRE1α (C931S) mutant nearly totally abrogated S-nitrosylation while the C951S mutant had a more modest effect (Fig. 4b,c) . These results are consistent with the notion that Cys-931 is the predominant nitrosylation site on IRE1α . To determine if this S-nitrosylation affected endonuclease activity, IRE1α -null mouse embryonic fibroblasts (MEFs) were used 26 . The MEFs were transfected with vectors expressing wild-type (WT) HA-tagged IRE1α or Cys mutant. NO-induced inhibition of IRE1α endonuclease activity was significantly ameliorated in MEFs expressing the IRE1α (C931S) mutant (Fig. 4d,e) . To our knowledge, this is the first demonstration that Cys931 is involved in allosteric regulation of IRE1α activity.
Next, to test the potential role of S-nitrosylation of IRE1α in cell death, we investigated the effects of the Cys mutants on NO-induced cell damage in IRE1α -null MEFs. Transient expression of IRE1α
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NO enhances eIF2α phosphorylation. As shown above, SNOC or GSNO can S-nitrosylate PERK, but not ATF6 (Fig. 4a) . Therefore, we investigated whether NO influences PERK activity/phosphorylation in SH-SY5Y neural cells. ER stress is known to result in the oligomerization and autophosphorylation of PERK, which then phosphorylates and thus inactivates eIF2α , although other kinases can also influence eIF2α activity 27 . Empirically, we found that NO induced a modest but detectable degree of phosphorylation of PERK (Fig. 5a) . Additionally, NO significantly enhanced phosphorylation of eIF2α in a concentration-dependent manner (Fig. 5a ). This resulting phosphorylation was transient and reached a peak level ~2 h after stimulation (Fig. 5b,c) . 
Discussion
The present study elucidated the effects of NO on major signaling pathways involved in the UPR. Previous reports had shown that NO reacts with PDI to form SNO-PDI in the ER lumen of human brains obtained from patients with several neurodegenerative diseases characterized by abnormal protein accumulation, including Parkinson's disease (PD) 20 . Cell-based models of neurodegeneration produced by exposure to NO or mitochondrial toxins known to induce Parkinsonism also displayed formation of SNO-PDI. S-Nitrosylation of PDI was shown to impair protein folding, thus promoting ER stress and the UPR, as observed in PD [28] [29] [30] . Here, we found that NO also reacts with the major ER stress sensors, IRE1α and PERK, thus attenuating UPR and contributing to cell death. Initially, we investigated whether the IRE1α -XBP1 pathway was affected by exposure to NO. We found that NO inhibited XBP1 mRNA splicing, but did not affect oligomerization or phosphorylation of IRE1α . Additionally, we found that pre-incubation with NO strongly inhibited XBP1 mRNA splicing induced by the well-known ER stress agent, thapsigargin. Moreover, our results show that exposure of SH-SY5Y neural cells to the PD-inducing agent MPP + , which generates NO, attenuated XBP1 mRNA splicing in an NOS inhibitor-dependent manner. From our findings, we concluded that NO inhibited the endonuclease activity of IRE1α but not the kinase activity of its cytosolic domain, and that IRE1α did not lose its ability to sense the accumulation of unfolded proteins in the ER lumen after exposure to NO.
Next, we determined the Cys residue of IRE1α targeted by NO. Analysis of the atomic structure of the cytosolic domain of IRE1α showed that Cys931 and Cys951 are both located in the KEN domain 24, 25 . Biotin-switch assay revealed that Cys931 is the predominant site of S-nitrosylation. Importantly, as evidence for a causal relationship of the effect of S-nitrosylation, transduction of IRE1α -null MEFs with the C931S mutant increased IRE1α endoribonuclease activity and protected cells from NO-induced cell death. These results indicate that the Cys931 residue of IRE1α is critical for redox signaling in the UPR. 
Collectively, we found that NO can S-nitrosylate IRE1α and PERK to regulate the UPR. Because the IRE1α -XBP1 pathway functions prominently as an anti-apoptotic pathway, this redox-mediated inhibition by NO hinders cell survival during ER stress. In contrast, prolonged activation of the PERK-eIF2α -ATF4/ATF6 pathways is known to induce cell death via induction of CHOP. Thus, in conjunction with its inhibition of the IRE1α branch of the UPR, NO activation of the PERK-eIF2α pathway would further sensitize neural cells to apoptosis. Taken together, we have elucidated the effects of S-nitrosylation on ER stress sensors that mediate the UPR, and thus contribute to cell death pathways. These findings have important implications for the development new therapeutic approaches for PD and other neurodegenerative diseases associated with nitrosative stress and abnormal protein accumulation.
Methods
Materials. Biotin-HPDP was purchased from Pierce Chemical Co. Thapsigargin was obtained from Wako Pure Chemical Ltd. All other reagents were obtained from Sigma-Aldrich. Antibodies against IRE1α and phospho-IRE1α , PERK, phospho-PERK, ATF6, eIF2α , phospho-eIF2α , and β -actin were purchased from Cell Signaling Technology.
Cell culture. Human SH-SY5Y cells and MEFs were maintained in Dulbecco's modified Eagle's medium supplemented with 10%(v/v) heat-inactivated fetal calf serum at 37 °C in humidified atmosphere of 5% CO 2 /95% air.
Mutagenesis.
Mutants of IRE1α were generated by substituting Ser for Cys residues using the QuickChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's instructions.
Luciferase assay. The XBP1-Luc reporter (ERAI system) and the phRL-TK (Promega, Madison, WI) were used in the dual luciferase assay. SH-SY5Y cells were seeded in 24-well plates and were then transfected with the plasmids. The cells were lysed after 24 h of transfection, and luciferase assay was performed. Reporter activity was measured using Dual-Luciferase 1000 Assay System kit (Promega) and a luminometer (Berthold, Bad Wildbad, Germany). The results are expressed as mean ± s.e.m. of three experiments. Each value is normalized to fold induction in mock-transfected cells.
RNA extraction and RT-PCR.
Total RNA of cells was extracted using TRI reagent (Sigma-Aldrich).
Transcriptor High Fidelity cDNA Synthesis Kit (Roche, Basel, Switzerland) was used to synthesize the cDNA according to the manufacturer's instructions. The cDNA was amplified by using 24 cycles of PCR. The following primers were used: human XBP1 sense primer, 5′ -TTA CGA GAG AAA ACT CAT GGC C-3′ ; human XBP1 antisense primer, 5′ -GGG TCC AAG TTG TCC AGA ATG C-3′ ; human EDEM1 sense primer, 5′ -TCC ATA TCC TCG GGT GAA TC-3′ ; human EDEM1 antisense primer, 5′ -AAA TTC CAC CAG GAG GGA AC-3′ ; human GRP78/BiP sense primer, 5′ -GTT TGC TGA GGA AGA CAA AAA GCT C-3′ ; human GRP78/BiP antisense primer 5′ -CAC TTC CAT AGA GTT TGC TGA TAA TTG-3′ ; human HRD1 sense primer 5′ -GCA CAC CTT CCC ACT CTT TG-3′ ; human HRD1 antisense primer 5′ -TGG CAC CAG TCA CCA TCT CT-3′ ; human CHOP sense primer, 5′ -CTC TGG CTT GGC TGA CTG A-3′ ; human CHOP antisense primer, 5′ -CTT CAG CTA GCT TGT CCA CT-3′ ; human β -actin sense primer, 5′ -CCT GAC GGC CAG GTC ATC-3′ ; human β -actin antisense primer, 5′ -GGA CTC GTC ATA CTC CTG-′ ' . PCR products were analyzed by performing agarose gel electrophoresis on a 1.5% gel.
Western blotting analysis. SH-SY5Y cells were treated as indicated above, harvested, washed with PBS, and lysed in ice-cold lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, and 1% NP-40 containing a protease inhibitor cocktail) for 10 min. For detecting of ATF6, the cells were preincubated with or without 50 μ M cycloheximide and 5 μ M MG-132 for 3 h and were further incubated during NO treatment. After quantification with Bradford assay, the proteins were boiled in sample loading buffer for 5 min and were electrophoresed by performing SDS-PAGE. The proteins (10 μ g/lane) were then transferred onto a PVDF membrane. The membrane was blocked with 5% BSA or non-fat dry milk in Tris-buffered saline containing 0.1% Tween-20 for 1 h at room temperature. The membrane was then incubated overnight at 4 °C with the antibodies indicated above. The proteins were detected using Western Lightning Ultra ECL-HRP substrate (PerkinElmer, Waltham, MA) and visualized using the ChemiDoc MP Imaging System (Bio-Rad).
Biotin-switch assay for S-nitrosylated proteins (SNO-P).
Cell lysates were prepared in HENT buffer (250 mM Hepes, pH7.5, 1 mM EDTA, 0.1 mM neocuproine, 0.1% SDS, and 1% Triton X-100). Protein concentration ranges were tested using the biotin-switch assay. Typically, 0.8 mg of cell lysate and up to 1.6 mg of tissue extract were used. Samples were mixed with blocking buffer (2.5% SDS and 20 mM methylmethanethiosulfonate (MMTS) in HEN buffer) and were incubated at 50 °C for 30 min to block free thiol groups. After removing excess MMTS by acetone precipitation, nitrosothiols were then reduced to free thiols by using 1 mM ascorbate. The newly formed thiols were linked to the sulfhydryl-specific biotinylating reagent biotin-HPDP. The biotinylated proteins were pilled down using streptavidin-agarose beads, and SNO-P remaining in the samples was detected by performing western blotting.
Assessment of cell viability. Cell viability was measured in triplicate in 24-well plates by performing a quantitative colorimetric assay with 5-(2, 4-bis[sodiooxysulfonyl]phenyl)-2-(4-nitrophenyl)-3-(4 -iodophenyl)-2H-tetrazole-3-ium (WST-1). Briefly, IRE1α -null MEFs were transfected with 0.4 μ g of each gene and were incubated for 24 h. Next, the cells were treated with 100 μ M GSNO for 24 h. Cell viability was expressed as the ration of signal obtained from treated cells and signal obtained from control cells multiplied by 100 (% control).
Statistical analysis.
All experiments were independently performed at least three times. All data are expressed as the mean ± s.e.m. Statistical comparisons were performed using an ANOVA with a Bonferroni correction conducted post hoc using Graphpad Prism 5 (Graphpad Software, La Jolla, CA, USA). P values < 0.05 were considered to be significant.
